The dual relationship between polypharmacy and frailty in nursing home residents: polypharmacy as a cause or a consequence?
Federica Giardino, Gelsomina Landi, Michele Arcopinto, Antonio Cittadini, Alberto Maria Marra
Author Information
- Federica Giardino: Department of Translational Medical Sciences, Interdisciplinary Research Centre in Biomedical Materials (C.R.I.B.), University Federico II of Naples, Via Pansini 5, 80131, Naples, Italy.
- Gelsomina Landi: Department of Translational Medical Sciences, Interdisciplinary Research Centre in Biomedical Materials (C.R.I.B.), University Federico II of Naples, Via Pansini 5, 80131, Naples, Italy.
- Michele Arcopinto: Department of Translational Medical Sciences, Interdisciplinary Research Centre in Biomedical Materials (C.R.I.B.), University Federico II of Naples, Via Pansini 5, 80131, Naples, Italy.
- Antonio Cittadini: Department of Translational Medical Sciences, Interdisciplinary Research Centre in Biomedical Materials (C.R.I.B.), University Federico II of Naples, Via Pansini 5, 80131, Naples, Italy.
- Alberto Maria Marra: Department of Translational Medical Sciences, Interdisciplinary Research Centre in Biomedical Materials (C.R.I.B.), University Federico II of Naples, Via Pansini 5, 80131, Naples, Italy. albertomaria.marra@unina.it. ORCID
No abstract text available.
- Jokanovic N, Tan ECK, Dooley MJ et al (2015) Prevalence ad factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc 16:535.e1-535.e12. https://doi.org/10.1016/j.jamda.2015.03.003
[DOI: 10.1016/j.jamda.2015.03.003]
- Saum K-U, Schöttker B, Meid AD et al (2017) Is polypharmacy associated with frailty in older people? results from the ESTHER Cohort Study. J Am Geriatr Soc 65:e27–e32. https://doi.org/10.1111/jgs.14718
[DOI: 10.1111/jgs.14718]
- Gnjidic D, Hilmer SN, Blyth FM et al (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65:989–995. https://doi.org/10.1016/j.jclinepi.2012.02.018
[DOI: 10.1016/j.jclinepi.2012.02.018]
- Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762
[DOI: 10.1016/S0140-6736(12)62167-9]
- Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 1:323–336. https://doi.org/10.1100/tsw.2001.58
[DOI: 10.1100/tsw.2001.58]
- Calcaterra L, Proietti M, Saporiti E, Nunziata V, Rolland Y, Vellas B, Cesari M (2021) Predictors of drug prescription in nursing home residents: results from the INCUR study. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02841-6 (PMID: 34546497)
[DOI: 10.1007/s11739-021-02841-6]
- Demougeot L, Rolland Y, Gérard S et al (2013) Incidence and economical effects of pneumonia in the older population living in French nursing homes: design and methods of the INCUR study. BMC Public Health 13:861. https://doi.org/10.1186/1471-2458-13-861
[DOI: 10.1186/1471-2458-13-861]
- Onder G, Liperoti R, Fialova D et al (2012) Polypharmacy in nursing home in Europe: results from the SHELTER Study. J Gerontol Ser A Biol Sci Med Sci 67A:698–704. https://doi.org/10.1093/gerona/glr233
[DOI: 10.1093/gerona/glr233]
- Tjia J, Velten SJ, Parsons C et al (2013) Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 30:285–307
[DOI: 10.1007/s40266-013-0064-1]
Aged
Frail Elderly
Frailty
Humans
Nursing Homes
Polypharmacy
